$GALE Recent Headlines FutureFuel shares rally on big

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$GALE Recent Headlines

FutureFuel shares rally on big profit jump 5:20 p.m. March 17, 2014 - Wallace Witkowski
3 best hedge fund managers of 2013 2:50 p.m. Jan. 22, 2014 - Insider Monkey
Top longs and shorts to watch 1:18 p.m. March 6, 2012 - The Trading Deck

Galena gets NOA for NeuVax patent app in Japan 12:59 p.m. Oct. 14, 2014 - Seeking Alpha
FDA clears Akynzeo for chemo-induced nausea and vomiting 10:50 a.m. Oct. 10, 2014 - Seeking Alpha
Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away? - Tale of the Tape 9:00 a.m. Oct. 9, 2014 - Zacks.com
Three Lessons From The Galena Scandal 11:02 a.m. Aug. 21, 2014 - Seeking Alpha
Galena Biopharma (GALE) Replaces CEO Mark Ahn 10:10 a.m. Aug. 21, 2014 - InvestorPlace.com
Galena CEO gets the boot 7:33 a.m. Aug. 21, 2014 - Seeking Alpha
Galena CEO Fired Following Stock-Promotions Scandal 7:16 a.m. Aug. 21, 2014 - TheStreet.com
Biotech Stock Mailbag: Exact Sciences, Galena, Amgen 7:22 a.m. Aug. 15, 2014 - TheStreet.com
Galena Biopharma's (GALE) CEO Mark Ahn on Q2 2014 Results - Earnings Call Transcript 9:17 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: GALENA BIOPHARMA, INC. 5:19 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
20 Cheap Stocks Under $10 Worth Zilch 5:40 a.m. Aug. 5, 2014 - InvestorPlace.com
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 5:22 p.m. Aug. 4, 2014 - Seeking Alpha
Galectin Pays Stock Promoters to Entice Retail Investors 12:34 p.m. July 28, 2014 - TheStreet.com
Galena Gives Sales Team Another Useless Product to Promote 9:41 a.m. July 22, 2014 - TheStreet.com
Galena secures U.S. rights to serotonin blocker 8:33 a.m. July 22, 2014 - Seeking Alpha
Biotech Accused in Stock-Pump Scheme 11:11 a.m. July 8, 2014 - Barrons.com
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 9:49 a.m. July 2, 2014 - TheStreet.com
Galena receives notice of allowance of NeuVax patent 8:14 a.m. July 1, 2014 - Seeking Alpha
Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal 9:52 a.m. June 18, 2014 - TheStreet.com
GALE-301 Phase 2a clinical trial enrollment complete 7:53 a.m. June 17, 2014 - Seeking Alpha


Galena Biopharma to Report Third Quarter 2014 Financial Results on Monday, November 3, 2014 7:06 a.m. Oct. 27, 2014 - GlobeNewswire
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 8:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan 7:05 a.m. Oct. 14, 2014 - GlobeNewswire
Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination 7:06 a.m. Oct. 8, 2014 - GlobeNewswire
Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update 4:15 p.m. Sept. 25, 2014 - GlobeNewswire
Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial 7:05 a.m. Sept. 9, 2014 - GlobeNewswire
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 7:06 a.m. Sept. 3, 2014 - GlobeNewswire
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer 7:05 a.m. Aug. 21, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014 7:06 a.m. July 29, 2014 - GlobeNewswire
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma for Zuplenz(R) Oral Soluble Film 7:16 a.m. July 22, 2014 - GlobeNewswire
Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film 7:06 a.m. July 22, 2014 - GlobeNewswire
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 5:30 a.m. July 4, 2014 - PR Newswire - PRF
Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S) 7:06 a.m. July 1, 2014 - GlobeNewswire
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
New Patents, Clinical Trial Updates, New Agreements, and FDA Approvals - Analyst Notes on Agile Therapeutics, Vanda, Galena, Nanosphere and Rockwell 5:10 a.m. June 26, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference 7:05 a.m. June 19, 2014 - GlobeNewswire
Galena Biopharma Recent Events will Continue to Weigh In on Shares, Analyst Report by BrokerBank Securities, Inc. 1:30 p.m. June 17, 2014 - PR Newswire - PRF
Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers 7:06 a.m. June 17, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Veteran Suicide Prevention: The Urgency Behind CVN's Push

Updated Category News Views 1

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Continue Reading
BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Updated Category News Views 6

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Continue Reading
Moore and RMI Forge Alliance for Data-Driven Success

Updated Category News Views 0

RMI and Moore Team Up for Strategic Evolution Let me tell ya, RMI Direct Marketing deciding to join forces with Moore’s AudienceFirst Media is a decision that’ll ripple through the data-driven waters for quite some time. They ain’t merging, mind you, but they’re definitely tying their ships together with a shared compass set on list management and brokerage...

Continue Reading
Dr. Anastasatos to Speak on Endoscopic Brow Lift in Crete

Updated Category News Views 3

Conference Spotlight: Endoscopic Brow Lift Plastic surgeons from across the globe are gathering in Crete, Greece, for a conference that promises to shake up the aesthetic world. Among the big names is Dr. John M. Anastasatos, who'll be lifting more than just eyebrows with his presentation on the endoscopic brow lift. This isn't just another facelift spiel—no sir—this...

Continue Reading
IMBC Kicks Off Fall Enrollment for Healthcare Training

Updated Category News Views 1

Diving into Hands-On Healthcare Training Opportunities Alright, let's talk straight about what's on the docket at the Institute of Medical and Business Careers (IMBC). They've just thrown open the doors for fall enrollment at their Erie and Pittsburgh campuses, focusing on getting folks trained up quick for the healthcare trenches. We're talking about roles that are...

Continue Reading
Soleno Therapeutics Faces Shareholder Legal Scrutiny

Updated Category News Views 2

Legal Storm Brews for Soleno's Execs When you see Kuehn Law stepping into the ring, you know someone’s ruffling feathers. And this time, the target is Soleno Therapeutics (NASDAQ:SLNO), a name that might ring bells for tech folks dabbling in biotech. They’re under the spotlight because a federal securities lawsuit claims a questionable playbook was in the shuffle....

Continue Reading
Business Leaders Push for Justice Reform Policy

Updated Category News Views 3

Business stepping up to bat for justice reform? Yeah, that’s what's shaking over in Washington, D.C. this Constitution Day. We're seeing a gathering of senior business execs, policymakers, and public safety advocates, intent on driving judicial reform in the U.S. Usually, the suits in these rooms talk about profit margins and quarterly results, but this time they're...

Continue Reading
Baystate Noble Plans Major ED Expansion for Future Needs

Updated Category News Views 1

A Trusted Name in Healthcare Steps Up When a healthcare player like Baystate Health decides to jump into the deep end with an expansion project, you know they're not just doodling on napkins. With a legacy stretching back to 1883, Baystate Health, anchored deeply in western New England, isn't just expanding for fun—it's a move to cement its position as a crucial...

Continue Reading
stackArmor Secures FedRAMP High: A Strategic Milestone

Updated Category News Views 2

stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...

Continue Reading
Equinix and CPP Investments Finalize $4B Data Center Deal

Updated Category News Views 6

Equinix's Nordic Expansion: A Bold Move Ever seen a chess master make a move that completely shifts the board? That's what Equinix, Inc. and CPP Investments just pulled off with their acquisition of atNorth. With a hefty price tag of $4 billion, they're not just playing around. This deal puts Equinix at the center of the Nordic data hub, solidifying its foothold in a...

Continue Reading

Top 5 Most Recently Viewed Articles

MoonLake Immunotherapeutics Faces Scrutiny Over Investor Concerns

Updated Category News Views 151

MoonLake Immunotherapeutics Under Investigation Recently, there has been significant attention surrounding MoonLake Immunotherapeutics (NASDAQ: MLTX) as the company faces an investigation over potential securities violations. Investors have raised concerns regarding whether they were misled by the company's communications regarding its clinical trials, particularly the...

Continue Reading
Innovation Sparks New Solutions in Artisanal Gold Mining Sector

Updated Category News Views 184

Transforming Artisanal Gold Mining through Innovative Solutions As gold prices soar, reaching unprecedented levels, the urgency to address the challenges posed by artisanal gold mining becomes even more crucial. Conservation X Labs (CXL) has recently shared a significant report that sheds light on vital technologies designed to mitigate the negative effects associated...

Continue Reading
Exploring the Surge of Insight Engines in Today's Market

Updated Category News Views 122

Understanding the Growth of the Insight Engines Market In today's data-driven world, insight engines are becoming crucial for businesses aiming to extract valuable information from massive datasets. The insight engines market is not just a passing trend; it is projected to experience substantial growth, expanding from USD 1.7 billion in 2023 to USD 5.6 billion by 2028....

Continue Reading
Feminine Hygiene Products Market Growth and Future Trends

Updated Category News Views 226

Market Growth and Projections The Feminine Hygiene Products Market is on a promising trajectory, projected to expand significantly in the coming years. Recent insights indicate that the market was valued at approximately USD 27.05 billion in 2023, with expectations to reach around USD 47.98 billion by 2032. This growth translates to a compound annual growth rate (CAGR) of...

Continue Reading
Caro Holdings and Drunken Horse Gin Join Forces for Growth

Updated Category News Views 168

Caro Holdings and Drunken Horse Gin Join Forces for Growth Caro Holdings Inc. is excited to announce a partnership with Drunken Horse Gin as they embark on a journey to enhance seasonal sales through innovative e-commerce strategies and targeted digital marketing campaigns. This collaboration aims to significantly boost Drunken Horse Gin's online presence during critical...

Continue Reading